Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (ARLZ) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 102 transactions totaling $21.6M, demonstrating a bearish sentiment with -$13.3M in net insider flow. The most recent transaction on Jun 4, 2018 involved a sale of 156,573 shares valued at $57.9K.
ARLZ Insider Activity Summary
Who Is Buying ARLZ Stock?
No significant insider buying has been recorded for ARLZ in the recent period.
Who Is Selling ARLZ Stock?
No significant insider selling has been recorded for ARLZ in the recent period.
Is Aralez Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARLZ is bearish with an Insider Alignment Score of 19/100 and a net flow of -$13.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ARLZ Frequently Asked Questions
Understanding ARLZ Insider Activity
Insider trading at Aralez Pharmaceuticals Inc. (ARLZ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading ARLZ stock, having executed 102 transactions in the past 90 days. The most active insider is Inc/bc Qlt (Executive), who has made 1 transactions totaling $15.0M.
Related Tools
Track Aralez Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at ARLZ file new Form 4 transactions